These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29780354)

  • 1. Targeting the Metastatic Bone Microenvironment by MicroRNAs.
    Haider MT; Taipaleenmäki H
    Front Endocrinol (Lausanne); 2018; 9():202. PubMed ID: 29780354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Bone Metabolism by microRNAs.
    Taipaleenmäki H
    Curr Osteoporos Rep; 2018 Feb; 16(1):1-12. PubMed ID: 29335833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer.
    Haider MT; Smit DJ; Taipaleenmäki H
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.
    Zhai Y; Tyagi SC; Tyagi N
    Biomed Pharmacother; 2017 Aug; 92():1073-1084. PubMed ID: 28618652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted microRNAs in bone metastasis.
    Taipaleenmäki H
    J Bone Miner Metab; 2023 May; 41(3):358-364. PubMed ID: 37031329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Exert Macro Effects on Cancer Bone Metastasis.
    Baier SR; Wan Y
    Curr Osteoporos Rep; 2016 Oct; 14(5):163-9. PubMed ID: 27464760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
    Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.
    Ji X; Chen X; Yu X
    Int J Mol Sci; 2016 Mar; 17(3):349. PubMed ID: 27005616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.
    Huang Q; Ouyang X
    Future Oncol; 2015; 11(1):141-51. PubMed ID: 25572789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.
    Gandellini P; Doldi V; Zaffaroni N
    Semin Cancer Biol; 2017 Jun; 44():132-140. PubMed ID: 28344166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Osteoclastogenesis and Bone Resorption by miRNAs.
    Inoue K; Ng C; Xia Y; Zhao B
    Front Cell Dev Biol; 2021; 9():651161. PubMed ID: 34222229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Targeting to Modulate Tumor Microenvironment.
    Kuninty PR; Schnittert J; Storm G; Prakash J
    Front Oncol; 2016; 6():3. PubMed ID: 26835418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis.
    Kang Y
    Endocrinol Metab (Seoul); 2016 Jun; 31(2):206-12. PubMed ID: 27184014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
    Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
    Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor-derived exosomes in bone metastasis.
    Li FX; Liu JJ; Xu F; Lin X; Zhong JY; Wu F; Yuan LQ
    Oncol Lett; 2019 Oct; 18(4):3935-3945. PubMed ID: 31579412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNAs in bone remodeling.
    Jing D; Hao J; Shen Y; Tang G; Li ML; Huang SH; Zhao ZH
    Int J Oral Sci; 2015 Sep; 7(3):131-43. PubMed ID: 26208037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in bone metastasis.
    Cheung DG; Buzzetti M; Di Leva G
    Expert Rev Endocrinol Metab; 2017 Nov; 12(6):451-461. PubMed ID: 30063434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.